4.3 Review

A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling

期刊

出版社

HINDAWI LTD
DOI: 10.1155/2017/3920195

关键词

-

向作者/读者索取更多资源

Pathological molecular mechanisms involved in myocardial remodeling contribute to alter the existing structure of the heart, leading to cardiac dysfunction. Among the complex signaling network that characterizes myocardial remodeling, the distinct processes are myocyte loss, cardiac hypertrophy, alteration of extracellular matrix homeostasis, fibrosis, defective autophagy, metabolic abnormalities, and mitochondrial dysfunction. Several pathophysiological stimuli, such as pressure and volume overload, trigger the remodeling cascade, a process that initially confers protection to the heart as a compensatory mechanism. Yet chronic inflammation after myocardial infarction also leads to cardiac remodeling that, when prolonged, leads to heart failure progression. Here, we review the molecular pathways involved in cardiac remodeling, with particular emphasis on those associated with myocardial infarction. A better understanding of cell signaling involved in cardiac remodeling may support the development of new therapeutic strategies towards the treatment of heart failure and reduction of cardiac complications. We will also discuss data derived from gene therapy approaches for modulating key mediators of cardiac remodeling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Cardiovascular Implications of microRNAs in Coronavirus Disease 2019

Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, Anna Laura Toni, Nicola Virtuoso, Albino Carrizzo, Paola Di Pietro, Guido Iaccarino, Carmine Vecchione, Michele Ciccarelli

Summary: The COVID-19 pandemic caused by SARS-CoV-2 is a global challenge, with cardiovascular involvement being a crucial complication. This report discusses the role of microRNAs in cardiovascular complications associated with COVID-19, highlighting their potential as biomarkers and predictors of cardiac and vascular damage.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)

Editorial Material Cell & Tissue Engineering

Modified Risk Tobacco Products and Cardiovascular Repair: Still Very Smoky

Claudia Cozzolino, Vittorio Picchio, Erica Floris, Francesca Pagano, Wael Saade, Mariangela Peruzzi, Giacomo Frati, Isotta Chimenti

Summary: Smoking habits have a significant impact on cardiovascular health by damaging differentiated and functional cells, as well as impairing reparative mechanisms. The introduction of modified tobacco risk products (MRPs) as alternative smoking devices has raised concerns regarding their effects on cardiovascular repair and regenerative cells. This review critically evaluates the limited available data on the molecular and cellular effects of MRPs on cardiovascular repair and regeneration.

CURRENT STEM CELL RESEARCH & THERAPY (2023)

Article Cardiac & Cardiovascular Systems

The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathy

Monica Cattaneo, Antonio P. Beltrami, Anita C. Thomas, Gaia Spinetti, Valeria Vincenza Alvino, Elisa Avolio, Claudia Veneziano, Irene Giulia Rolle, Sandro Sponga, Elena Sangalli, Anna Maciag, Fabrizio Dal Piaz, Carmine Vecchione, Aishah Alenezi, Stephen Paisey, Annibale A. Puca, Paolo Madeddu

Summary: The longevity-associated variant of the BPIFB4 gene, known as LAV-BPIFB4, can improve heart function and perfusion in older people, and prevent the decline of heart performance. Gene therapy with LAV-BPIFB4 can reverse the age-related decline in cardiac function, improve microvasculature density and pericyte coverage.

CARDIOVASCULAR RESEARCH (2023)

Article Nutrition & Dietetics

Natural Activators of Autophagy Reduce Oxidative Stress and Muscle Injury Biomarkers in Endurance Athletes: A Pilot Study

Alessandra D'Amico, Chiara Fossati, Fabio Pigozzi, Paolo Borrione, Mariangela Peruzzi, Simona Bartimoccia, Filippo Saba, Annachiara Pingitore, Giuseppe Biondi-Zoccai, Luigi Petramala, Fabrizio De Grandis, Daniele Vecchio, Luca D'Ambrosio, Sonia Schiavon, Luigi Sciarra, Cristina Nocella, Elena Cavarretta

Summary: This study aimed to investigate the effects of a mixture containing three compounds on muscle injury biomarkers in endurance athletes. The results showed that the intake of this mixture significantly reduced oxidative stress and positively modulated autophagy, resulting in a significant decrease in muscle injury biomarkers.

NUTRIENTS (2023)

Article Cardiac & Cardiovascular Systems

Role of Dickkopf-3 in Blood Pressure Regulation in Mice and Hypertensive Rats

Carla Letizia Busceti, Albino Carrizzo, Franca Bianchi, Massimiliano De Lucia, Antonio Damato, Chiara Cazzin, Eleonora Venturini, Paola Di Pietro, Roxana Paula Ginerete, Luisa Di Menna, Maria Cotugno, Rosita Stanzione, Simona Marchitti, Serena Migliarino, Michele Ciccarelli, Sebastiano Sciarretta, Valeria Bruno, Giuseppe Battaglia, Francesco Fornai, Massimo Volpe, Speranza Rubattu, Ferdinando Nicoletti, Carmine Vecchione

Summary: Dkk3 plays a crucial role in cardiovascular homeostasis, and its deficiency leads to hypertension and impaired vascular function, which can be rescued by restoring Dkk3 expression. This effect is achieved through promoting VEGF expression and activating the VEGF/Akt/eNOS hypotensive pathway.

CIRCULATION RESEARCH (2023)

Editorial Material Cardiac & Cardiovascular Systems

Targeting the CXCR4/DEL-1 axis to tackle atherosclerosis

Paola Di Pietro, Carmine Vecchione, Albino Carrizzo

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Artificial intelligence in cardiovascular prevention: new ways will open new doors

Michele Ciccarelli, Francesco Giallauria, Albino Carrizzo, Valeria Visco, Angelo Silverio, Arturo Cesaro, Paolo Calabro, Nicola De Luca, Costantino Mancusi, Daniele Masarone, Giuseppe Pacileo, Nidal Tourkmani, Carlo Vigorito, Carmine Vecchione

Summary: The use of artificial intelligence in cardiovascular disease has been increasingly recognized for its ability to provide valuable patient-centric insights and improve diagnosis and treatment through the analysis of real-world data.

JOURNAL OF CARDIOVASCULAR MEDICINE (2023)

Review Medicine, General & Internal

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets

Angelo Silverio, Francesco Paolo Cancro, Luca Esposito, Michele Bellino, Debora D'Elia, Monica Verdoia, Maria Giovanna Vassallo, Michele Ciccarelli, Carmine Vecchione, Gennaro Galasso, Giuseppe De Luca

Summary: The control of cardiovascular risk factors, promotion of a healthy lifestyle, and antithrombotic therapy are important for secondary prevention after acute coronary syndrome (ACS). Identification of novel risk factors and targets is essential to optimize preventive strategies for patients who have recurrent ischemic events despite optimal control of traditional risk factors and pharmacological therapy.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, General & Internal

Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand?

Michele Bellino, Gennaro Galasso, Angelo Silverio, Michele Tedeschi, Ciro Formisano, Stefano Romei, Luca Esposito, Francesco Paolo Cancro, Maria Giovanna Vassallo, Giulio Accarino, Monica Verdoia, Francesca Maria Di Muro, Carmine Vecchione, Giuseppe De Luca

Summary: Current research on cardiovascular prevention focuses on risk-stratification and management of coronary artery disease (CAD) patients. The aim is to determine the causes and risk factors of CAD and to identify ways to counteract them. The role of LDL cholesterol (LDL-C) as a key factor in atherosclerotic cardiovascular disease (ASCVD) has been well established, and inhibiting PCSK9, a regulator of LDL-C levels, has shown promising results in reducing LDL-C.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Chemistry, Analytical

Wearable Technologies and AI at the Far Edge for Chronic Heart Failure Prevention and Management: A Systematic Review and Prospects

Angela-Tafadzwa Shumba, Teodoro Montanaro, Ilaria Sergi, Alessia Bramanti, Michele Ciccarelli, Antonella Rispoli, Albino Carrizzo, Massimo De Vittorio, Luigi Patrono

Summary: Smart wearable devices enable personalized at-home healthcare by collecting patient health data and facilitating the development of intelligent platforms. Accurate analysis of data obtained from wearables is crucial for interpreting health data and supporting diagnosis and management of diseases. The combination of edge computing and AI provides real-time and privacy-preserving data analysis solutions.

SENSORS (2023)

Article Cardiac & Cardiovascular Systems

Arterial hypertension in patients with takotsubo syndrome: prevalence, long-term outcome, and secondary preventive strategies: a report from the Takotsubo Italian Network register

Angelo Silverio, Eduardo Bossone, Guido Parodi, Fernando Scudiero, Marco Di Maio, Olga Vriz, Michele Bellino, Concetta Zito, Gennaro Provenza, Giuseppe Iuliano, Mario Cristiano, Giuseppina Novo, Ciro Mauro, Fausto Rigo, Pasquale Innelli, Jorge Salerno-Uriarte, Matteo Cameli, Giuliana Tremiterra, Carmine Vecchione, Francesco Antonini-Canterin, Gennaro Galasso, Rodolfo Citro, Takotsubo Italian Network

Summary: This study aimed to investigate the long-term outcomes of takotsubo syndrome (TTS) patients with and without hypertension (HT), and evaluate the effectiveness of treatment with beta-blockers (BBs) and/or renin-angiotensin-aldosterone system inhibitors (RAASi). The study found that HT does not affect the long-term risk of adverse events in TTS patients, but increases the effectiveness of BB treatment. Therefore, tailored pharmacological therapy should be considered for TTS patients with HT.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis

Germano Junior Ferruzzi, Angelo Silverio, Arturo Giordano, Nicola Corcione, Michele Bellino, Tiziana Attisano, Cesare Baldi, Alberto Morello, Giuseppe Biondi-Zoccai, Rodolfo Citro, Carmine Vecchione, Gennaro Galasso

Summary: This study found that the presence of moderate to severe mitral regurgitation (MR) in patients with low flow, low-gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) is associated with a worse clinical outcome at 1 year. TAVR may improve MR severity in some patients, resulting in potential benefits after discharge.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Editorial Material Endocrinology & Metabolism

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease

Paola Di Pietro, Carmine Izzo, Albino Carrizzo

FRONTIERS IN ENDOCRINOLOGY (2023)

Review Biochemistry & Molecular Biology

A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer

Davide Bellini, Marika Milan, Antonella Bordin, Roberto Rizzi, Marco Rengo, Simone Vicini, Alessandro Onori, Iacopo Carbone, Elena De Falco

Summary: Radiomics is a novel advanced approach to imaging, extracting quantitative and reproducible data from radiological images using sophisticated mathematical analysis. Radiogenomics, defined as the integration of radiology and genomics, explores the relationship between specific features extracted from radiological images and genetic or molecular traits of a particular disease. Despite advancements, standardized protocols in clinical practice are still lacking.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据